local rate of recurrence at similar average original tumor sites for RITA devices was 26.8% pared to 60.3% for the Radiotherapeutics (Boston Scientific) expandable electrode and 42.9% for the Radionics Cool-tip clustered triple electrode. Authors called the difference between the two types of expandable electrodes (RITA and Radiotherapeutics-BSC) remarkable, because >40 lesions of similar size were treated with each system. The study was independently conducted and not sponsored by RITA or any other RFA-systems manufacturer.А(这项研究是独立进行,与RITA或其他任何厂商无关)Р地位РRITA公司产品作为先进技术代表、行业标准制定者;?拥有多项技术专利;强大的研发能力;?获得学术界及国际著名医疗机构的广泛认可;?国际许多重要医学研究均采用RITA产品的治疗数据。Р专利证书Р原理Р射频发生器460千赫兹的交变电流Р肿瘤组织中的离子产生高频振荡Р摩擦生热局部温度可达90℃以上Р肿瘤组织凝固性坏死РRITA1500X独有的技术优势Р最大射频发生器输出功率?最大单次单针消融范围?最丰富的电极针型号规格?最先进的外科手术无血切割技术?最新技术的腔道内射频消融技术